Wanbury Share Price

Wanbury Share Price

330.65
-7.75 (-2.29%)
22 Jul, 2026 • 03:30 PM
NSE: WANBURY |

Wanbury Annualised Returns

1 Year

21.18%

3 Years

91.48%

5 Years

31.08%

10 Years

23.19%

Wanbury Share Price Today


As of 23 Jul 2026, Wanbury share price is ₹330.6. The stock opened at ₹339 and had closed at ₹338.4 the previous day. During today’s trading session, Wanbury share price moved between ₹321.95 and ₹339.00, with an average price for the day of ₹330.48. Over the last 52 weeks, the stock has recorded a low of ₹161.50 and a high of ₹358.85. In terms of performance, Wanbury share price has increased by 83.4% over the past six months and has increased by 21.18% over the last year.

Wanbury Stock Performance

1W Return-4.09%
1M Return21.16%
6M Return78.28%
1Y Return25.60%
3Y Return533.43%
Today's High₹339
Today's Low₹321.95
52-Week High₹358.85
52-Week Low₹161.5
Prev. Close₹338.40
Open₹339.00
Face Value₹10
Mkt Cap (Cr.)₹1,155
PE Ratio17.46

Wanbury Share Price Chart

Wanbury Company background

Founded in: 1988
Wanbury Limited, formerly known Pearl Organics Limited was incorporated in August, 1988. The Company attained its present name in September 2004. The Company is engaged in the business of pharmaceutical and related activities, including research.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 200708, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Honble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/ each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/ each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively.The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.The novel product Cdense Gems was launched in May, 2008. The Company completed the restructuring of the Formulation Division during the year 2013. It launched, MyotolF, targeted at female infertility in 2013, it launched Folinine. The Companys newly launched products MyotolF (to treat polycystic ovarian syndrome) and CalK2 (in prevention and management of Osteoporosis) were labelled as one of the best launches in 2014.

Wanbury Financial Highlights


For the full year FY2025–2026, revenue reached ₹603.01 crore and profit touched at ₹30.53 crore.
Read More
Wanbury SIP Returns Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 7,20,445 in 5 years with a gain of 4,20,445 (+140.15%)

Wanbury Fundamental

Market Cap (in crs)

1,155.27

Face Value

10

Turnover (in lacs)

1,938.72

Key Metrics

Qtr Change %
New 52W High in past week
28
Dividend yield 1yr %
0

Wanbury Key Financials

View more
Loading chart...
Wanbury Quarterly Revenue
Wanbury Yearly Revenue
Wanbury Quarterly Net Profit/Loss
Wanbury Yearly Net Profit/Loss

Wanbury Result Highlights

  • Wanbury reported a 17.5% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a decline of 8.1%.

  • Its expenses for the quarter were down by 14.0% QoQ and 2.2% YoY.

  • The net profit decreased 84.8% QoQ and decreased 88.1% YoY.

  • The earnings per share (EPS) of Wanbury stood at 0.3 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Wanbury Technical Analysis

Moving Averages Analysis
330.65
Current Price
Bullish Moving Averages
14
Bearish Moving Averages
2
5 EMA
333.20
10 EMA
324.40
12 EMA
320.80
20 EMA
309.40
26 EMA
303.10
50 EMA
287.80
100 EMA
272.50
200 EMA
261.00
Delivery & Volume
Loading chart...

Day

48.00%

Week

38.20%

Month

29.60%

Delivery & Volume

330.53
Pivot
Resistance
First Resistance
339.12
Second Resistance
347.58
Third Resistance
356.17
Support
First Support
322.07
Second support
313.48
Third Support
305.02
Relative Strength Index
64.27
Money Flow Index
77.90
MACD
17.71
MACD Signal
14.08
Average True Range
18.52
Average Directional Index
27.76
Rate of Change (21)
21.16
Rate of Change (125)
52.70
Compare

Wanbury Shareholding Pattern

Promoter
43%
Foreign Institutions
0.9%
Domestic Institutions
0.1%
Public
56%

Wanbury Latest News

22 JUL 2026
20 JUL 2026
17 JUL 2026

Wanbury share price is ₹330.65 in NSE and ₹330.5 in BSE as on 22/7/2026.

Wanbury share price in the past 1-year return was 25.6. The Wanbury share hit a 1-year low of Rs. 161.5 and a 1-year high of Rs. 358.85.

The market cap of Wanbury is Rs. 1155.27 Cr. as of 22/7/2026.

The PE ratios of Wanbury is 17.46 as of 22/7/2026.

The PB ratios of Wanbury is 7.99 as of 22/7/2026

You can easily buy Wanbury shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Wanbury share price is ₹358.85 and ₹161.5 as of 22/7/2026.

Please be aware that Wanbury stock prices are subject to continuous fluctuations due to various factors.